P. Scarabin

Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging

P. Touboul, P. Prati, P. Scarabin, 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.

P. Scarabin, L. Guize, E. Oger, 2001, Thrombosis research.

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.

P. Scarabin, L. Guize, J. Amiral, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Risk of venous thrombosis with hormone replacement therapy

P. Scarabin, 1996, The Lancet.

Soluble thrombomodulin as predictor of incident coronary heart disease

P. Scarabin, L. Guize, L. Mennen, 1999, The Lancet.

Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME Study

D. Arveiler, G. Luc, J. Ruidavets, 2000, Journal of Human Hypertension.

Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Study.

D. Arveiler, G. Luc, J. Ruidavets, 2001, Atherosclerosis.

Elevated plasma fibrin D‐dimer as a risk factor for vascular dementia: the Three‐City cohort study

M. Giroud, P. Scarabin, P. Ducimetiere, 2009, Journal of thrombosis and haemostasis : JTH.

Platelet Aggregation Related to age in Diabetes Mellitus

P. Scarabin, C. Lecrubier, F. Grauso, 1979, Thrombosis and Haemostasis.

The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

S. Humphries, D. Arveiler, G. Luc, 1995, Thrombosis and Haemostasis.